Earnings History Data for Celyad Oncology SA (CYAD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Celyad Oncology SA
Celyad SA is a biopharmaceutical company. The Company develops and commercializes cell based regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. Celyad SA is based in Mont-Saint-Guibert, Belgium.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23-03-2023 | AH | After the close (Mar 23) |
CYAD | Celyad Oncology SA | 25.76 | N/A | 0.00 | 0.00 | Celyad Oncology GAAP EPS of -€1.81 [3/23/2023 5:07 PM] |
0.8754 | 0.01 (0.93%) |
0.92 | 0.03 (3.51%) |
0.46 - 3.07 | 3,814 | 30,000 | 1,063 | |
| 05-08-2022 | PM | Before the open (Aug 5) |
CYAD | Celyad Oncology SA | 39.54 | N/A | 0.00 | 0.00 | Celyad Oncology GAAP EPS of -€0.62 [8/5/2022 1:09 AM] |
2.44 | 0.41 (20.20%) |
2.09 | 0.06 (2.96%) |
1.51 - 5.32 | 222,971 | 810,000 | 5,780 | |
| 24-03-2022 | AH | After the close (Mar 24) |
CYAD | Celyad Oncology SA | 52.64 | N/A | 0.00 | 0.00 | Celyad Oncology GAAP EPS of -€1.70 [3/24/2022 4:04 PM] |
2.20 | -0.21 (-8.71%) |
2.33 | -0.02 (-0.85%) |
1.67 - 7.30 | 4,058 | 23,366 | 100 | |
| 04-08-2021 | AH | After the close (Aug 4) |
CYAD | Celyad Oncology SA | 65.54 | N/A | 0.00 | 0.00 | Celyad Oncology EPS beats by $0.29 [8/4/2021 4:14 PM] |
4.17 | -0.09 (-2.11%) |
4.24 | -0.02 (-0.47%) |
3.94 - 10.87 | 28,222 | 30,000 | 2,392 | |